Skip to search formSkip to main contentSkip to account menu

Norditropin

Known as: Norditropin Simplexx, Norditropine 
National Institutes of Health

Related topics

Related topics

3 relations
1.5 ML Somatropin 6.67 MG/ML Pen Injector [Norditropin]

Broader (2)

Human Growth HormoneSomatropin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Trial Investigating the Long-Term Efficacy and Safety of Two Doses of Norditropin® (Somatropin; Recombinant Human Growth Hormone) in Japanese Children with Short Stature Due to Noonan Syndrome Over…
2018
2018
Comparing the Cumulative Dose of Growth Hormone Therapy Using Body Weight-Based Dosing Versus Body Surface Area-Based Dosing in Children with Turner Syndrome - Data from the ANSWER Study
• The theoretical BSA-based dose of 1.46 mg/d was derived from observed dose vs BSA data that best corresponded with an ideal… 
2014
2014
Evaluation of the Safety and Usability of FlexPro ® 30 mg/3 ml, for the Delivery of Norditropin ® in Patients Requiring GH Therapy
2011
2011
Анализ результатов лечения различных форм низкорослости генно-инженерным гормоном роста у детей Липецкой области
The results of evaluation of efficacy of genetically engineered growth hormone in the treatment of 50 children with short stature… 
2010
2010
PDB19 ECONOMIC EVALUATION OF SOMATROPIN (NORDITROPIN) FOR THE TREATMENT OF SHORT CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA)
size and dose spread assumptions. CONCLUSION: Cost of GH waste can be an important consideration when evaluating GH devices. 
2008
2008
FDA approves pediatric indication for Norditropin
The FDA has approved Novo Nordisk's Norditropin for the treatment of short stature in children who are small for gestational age… 
2002
2002
Efficiency of norditropin, human growth hormone, in the treatment of children with somatotropic insufficiency